News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
326 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18222)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
Disc Medicine Announces Presentation of Clinical Data from First-in-Human Phase 1 Study of DISC-0974 at European Hematology Association (EHA) 2022 Congress
Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, announced today that clinical data of DISC-0974 will be presented at the upcoming European Hematology Association (EHA) Annual Congress being held in Vienna June 9-12.
May 16, 2022
·
2 min read
Business
Innovation community at The Oxford Science Park expands further as companies move into the Hayakawa Building
The innovation community at The Oxford Science Park, one of Europe’s leading locations for science and technology companies, continues to expand as firms move into the newly refurbished Hayakawa Building.
May 16, 2022
·
3 min read
UroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Office Nephrostomy Tube Administration of JELMYTO®, the only Non-Surgical, Kidney-Sparing Treatment for Adults with Low Grade Upper Tract Urothelial Cancer
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, today highlights new data on real-world experience utilizing the antegrade approach via nephrostomy tube for administration of JELMYTO® (mitomycin) for pyelocalyceal solution.
May 16, 2022
·
11 min read
Business
Inventiva reports 2022 First Quarter Financial Information and provides clinical development update
Inventiva reported its cash position as of March 31, 2022 and its revenues for the first quarter of 20221, and provided an update on its clinical programs.
May 16, 2022
·
11 min read
Business
Albireo Reports Q1 2022 Financial Results and Business Update
Albireo Pharma, Inc., a rare liver disease company developing novel bile acid modulators, provided a business update and reported financial results for the quarter ended March 31, 2022.
May 16, 2022
·
19 min read
BioMidwest
AGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa
Applied Genetic Technologies Corporation reported positive three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa.
May 16, 2022
·
8 min read
Biotech Bay
Cytokinetics Announces Three Upcoming Presentations at the European Society of Cardiology Heart Failure 2022 Congress
Cytokinetics, Incorporated announced three Late-Breaking Science presentations at Heart Failure 2022, an International Congress of the European Society of Cardiology taking place online and in Madrid, Spain from May 21, 2022 – May 24, 2022.
May 16, 2022
·
5 min read
Business
Acumen Pharmaceuticals Reports Financial Results for First Quarter 2022 and Business Highlights
Acumen Pharmaceuticals, Inc. reported financial results for the quarter ended March 31, 2022 and provided a business update.
May 16, 2022
·
12 min read
Business
Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
Icosavax, Inc. reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.
May 16, 2022
·
9 min read
Business
Arcellx Appoints Olivia Ware to Board of Directors
Arcellx, Inc. announced the appointment of Olivia Ware to its Board of Directors.
May 16, 2022
·
5 min read
Previous
26 of 33
Next